Bioelectric Medicine Market Size, Share, Outlook 2018-2026
Bioelectric medicine is a new and innovative approach to diagnose and treat injuries and diseases. All major organs of the body are connected to the nerves, which allows the brain to monitor and regulate the functions of the organs. Bioelectric medicine refers to the usage of a device to modulate and read the electrical activity within the body’s nervous systems. Nerve blocking devices or nerve stimulating devices that are held against the skin or implanted on a nerve have the potential to regulate specific nerve activity, make specific changes in organ function, and also restore health, without much complicated side effects of pharmaceutical agents. Bioelectric medicine technology is used to record, block, and stimulate neural signals to change the way diseases and injuries are treated. It is also used for the treatment of conditions such as cancer, paralysis, rheumatoid arthritis, and diabetes. Electroceuticals are alternatives to drug based remedies.
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1757
Mergers and acquisitions, advancements in technology, and innovations such as non-invasive devices in the field of bioelectric medicines are the major factors driving growth of the bioelectric medicine market. For instance, in 2016, GlaxoSmithKline Plc. (GSK) merged with Google’s parent company Alphabet to set up a new bioelectric company called Galvani Bioelectronics, which will benefit over 2 billion people who are suffering from chronic diseases. GSK invested around US$ 615 million for the development of Galvani Bioelectronics. In 2015, Synapse Electroceutical Technology, a UK-based company launched a new product Accel-Heal, which is a non-invasive class 2A medical device. The device also promotes healing of leg ulcers by using electrical energy. Accel-Heal delivers a sequence of low level, pre-programmed and sub sensory electrical energy through surface of the skin.
Synapse Electroceutical Technology has a product for venous leg ulcer management in the pipeline, which is expected to fuel growth of the bioelectric medicine market over the forecast period. Other factors that boost growth of the bioelectric medicine market include increasing number of diseases in geriatric population such as cardiac arrhythmias, Parkinson’s disease, Alzheimer’s disease, epilepsy, and depression, and rise in chronic diseases such as neurological and cardiac disorders. According to a study conducted by Journal of Family Medicine and Primary Care in 2017, four major chronic diseases including cancer, cardiovascular disease, diabetes, and chronic respiratory diseases were the major cause for 82% deaths in India. According to a study conducted by World Health Organization (WHO) in 2017, non-communicable diseases are expected to contribute to death of 52 million people by 2030 globally.
Click To Continue Reading on Bioelectric Medicine Market
You may be interested
Data Loss Prevention Market: Taking New Steps to Meet the Challenges and Enter in IndustryMohit Joshi - November 12, 2018
Global Data Loss Prevention Market Provide Forecast Report 2018 presents an market Industry analysis of the report which researched industry growth, market share, size and demands over forecast period…
Virtual Reality Content Creation Market Cohesive and Predictive Business Strategy Till 2026Mohit Joshi - November 12, 2018
Global Virtual Reality Content Creation Market Provide Forecast Report 2018 presents an market Industry analysis of the report which researched industry growth, market share, size and demands over forecast…
Electrochromic Glass Market Growth Rate, Key Vendors, Trends, Drivers & Opportunities to 2026Mohit Joshi - November 12, 2018
Global Electrochromic Glass Market Provide Forecast Report 2018 presents an market Industry analysis of the report which researched industry growth, market share, size and demands over forecast period (2018-…